InvestorsHub Logo
Followers 4
Posts 929
Boards Moderated 0
Alias Born 08/15/2006

Re: SF Wolf post# 1268

Monday, 02/27/2017 9:44:22 AM

Monday, February 27, 2017 9:44:22 AM

Post# of 21540
SF:

Great post.

I also believe it was a HUGE tell that the Chief Science Officer (Dr. Alkon) discussed in detail the science of Bryostatin and the 3 compassionate use patients.

If the CEO had presented info about these patients, it wouldn't have the strength of the CSO talking about these 3 patients in glowing terms of recovery.

Dr. Alkon is a 30-year research veteran of the NIH and I don't believe he would present information on patients that isn't backed by objective testing and observation.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News